Ion Selectivity, Current, and Water Flow Regulation in Ti 3 C 2 MXene Nanopores
Nano Letters · 07.08.2024 · 24 (31) · 9487-9493
DOI: 10.1021/acs.nanolett.4c01892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 01.07.2024. Verfasst von Sangyeon Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), 77 Cheongam-Ro, Nam-Gu, Pohang, Gyeongbuk 37673, Republi…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Korea Institute for Advancement of Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), 77 Cheongam-Ro, Nam-Gu, Pohang, Gyeongbuk 37673, Republic of Korea.
- Department of Mechanical Engineering, College of Engineering, Dong-Eui University, 176 Eomgwang-Ro, Busanjin-Gu, Busan 47340, Republic of Korea.
ORCID-Profile: Hyung Gyu Park, Myung Eun Suk
Förderung
- National Research Foundation of Korea
- Korea Institute for Advancement of Technology
Zitieren
APA
Lee, S., Go, S. G., Park, H. G., & Suk, M. E. (2024). Ion Selectivity, Current, and Water Flow Regulation in Ti 3 C 2 MXene Nanopores. Nano Letters, 24(31), 9487-9493. https://doi.org/10.1021/acs.nanolett.4c01892
Vancouver
Lee S, Go SG, Park HG, Suk ME. Ion Selectivity, Current, and Water Flow Regulation in Ti 3 C 2 MXene Nanopores. Nano Letters. 2024;24(31):9487-9493. doi:10.1021/acs.nanolett.4c01892
BibTeX
@article{Lee2024,
author = {Lee, Sangyeon and Go, Su-Gwang and Park, Hyung Gyu and Suk, Myung Eun},
title = {Ion Selectivity, Current, and Water Flow Regulation in Ti 3 C 2 MXene Nanopores},
journal = {Nano Letters},
year = {2024},
volume = {24},
number = {31},
pages = {9487--9493},
doi = {10.1021/acs.nanolett.4c01892}
}
EUVIMED